Literature DB >> 31465221

Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.

Ho Shin Kim1, Jared T Hammill1, Daniel C Scott2, Yizhe Chen1, Jaeki Min3, Jonah Rector1, Bhuvanesh Singh4, Brenda A Schulman2,5, R Kiplin Guy1.   

Abstract

Chemical control of cullin neddylation is attracting increased attention based largely on the successes of the NEDD8-activating enzyme (E1) inhibitor pevonedistat. Recently reported chemical probes enable selective and time-dependent inhibition of downstream members of the neddylation trienzymatic cascade including the co-E3, DCN1. In this work, we report the optimization of a novel class of small molecule inhibitors of the DCN1-UBE2M interaction. Rational X-ray co-structure enabled optimization afforded a 25-fold improvement in potency relative to the initial screening hit. The potency gains are largely attributed to additional hydrophobic interactions mimicking the N-terminal acetyl group that drives binding of UBE2M to DCN1. The compounds inhibit the protein-protein interaction, block NEDD8 transfer in biochemical assays, engage DCN1 in cells, and selectively reduce the steady-state neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification.

Entities:  

Year:  2019        PMID: 31465221      PMCID: PMC7228038          DOI: 10.1021/acs.jmedchem.9b00410

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  41 in total

1.  Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.

Authors:  Shuai Wang; Lijie Zhao; Xiao-Jing Shi; Lina Ding; Linlin Yang; Zhi-Zheng Wang; Dandan Shen; Kai Tang; Xiao-Jing Li; Maa Mamun; Huiju Li; Bin Yu; Yi-Chao Zheng; Shaomeng Wang; Hong-Min Liu
Journal:  J Med Chem       Date:  2019-03-04       Impact factor: 7.446

Review 2.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design?

Authors:  Timothy J Ritchie; Simon J F Macdonald
Journal:  Drug Discov Today       Date:  2009-09-01       Impact factor: 7.851

Review 3.  Targeting the neddylation pathway in cells as a potential therapeutic approach for diseases.

Authors:  Jie Ying; Miaomiao Zhang; Xiaoyan Qiu; Yu Lu
Journal:  Cancer Chemother Pharmacol       Date:  2018-02-15       Impact factor: 3.333

4.  SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation.

Authors:  Alexander Y Kim; Claire C Bommeljé; Benjamin E Lee; Yoshihiro Yonekawa; Lydia Choi; Luc G Morris; Guochang Huang; Andrew Kaufman; Russel J H Ryan; Bing Hao; Y Ramanathan; Bhuvanesh Singh
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

5.  Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.

Authors:  Simon G Talbot; Pornchai O-charoenrat; Inderpal S Sarkaria; Ronald Ghossein; Pabbathi Reddy; Ivan Ngai; Christina N Cordeiro; Richard J Wong; Mark G Kris; Valerie W Rusch; Bhuvanesh Singh
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344

6.  The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.

Authors:  Cherry L Estilo; Pornchai O-Charoenrat; Ivan Ngai; Snehal G Patel; Pabbathi G Reddy; Su Dao; Ashok R Shaha; Dennis H Kraus; Jay O Boyle; Richard J Wong; David G Pfister; Joseph M Huryn; Ian M Zlotolow; Jatin P Shah; Bhuvanesh Singh
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

7.  Targeted inhibition of the COP9 signalosome for treatment of cancer.

Authors:  Anita Schlierf; Eva Altmann; Jean Quancard; Anne B Jefferson; René Assenberg; Martin Renatus; Matthew Jones; Ulrich Hassiepen; Michael Schaefer; Michael Kiffe; Andreas Weiss; Christian Wiesmann; Richard Sedrani; Jörg Eder; Bruno Martoglio
Journal:  Nat Commun       Date:  2016-10-24       Impact factor: 14.919

8.  Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.

Authors:  Matthew J Keuss; Yann Thomas; Robin Mcarthur; Nicola T Wood; Axel Knebel; Thimo Kurz
Journal:  J Cell Sci       Date:  2016-02-18       Impact factor: 5.285

Review 9.  Cullin-RING ligases in regulation of autophagy.

Authors:  Danrui Cui; Xiufang Xiong; Yongchao Zhao
Journal:  Cell Div       Date:  2016-06-10       Impact factor: 5.130

Review 10.  Drugging the undruggables: exploring the ubiquitin system for drug development.

Authors:  Xiaodong Huang; Vishva M Dixit
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

View more
  7 in total

1.  Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells.

Authors:  Yi-Fan Chen; Run-Zhi Liu; Wen-Wen Ying; Yue-Ning Yang; Sen-Feng Xiang; Xue-Jing Shao; Ji Cao; Yan-Qi Zhang; Bo Yang; Qiao-Jun He; Mei-Dan Ying
Journal:  Acta Pharmacol Sin       Date:  2022-09-22       Impact factor: 7.169

2.  Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M.

Authors:  Ho Shin Kim; Jared T Hammill; Daniel C Scott; Yizhe Chen; Amy L Rice; William Pistel; Bhuvanesh Singh; Brenda A Schulman; R Kiplin Guy
Journal:  J Med Chem       Date:  2021-05-04       Impact factor: 7.446

3.  Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity.

Authors:  Haibin Zhou; Jianfeng Lu; Krishnapriya Chinnaswamy; Jeanne A Stuckey; Liu Liu; Donna McEachern; Chao-Yie Yang; Denzil Bernard; Hong Shen; Liangyou Rui; Yi Sun; Shaomeng Wang
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 4.  Targeting neddylation E2s: a novel therapeutic strategy in cancer.

Authors:  Yi-Chao Zheng; Yan-Jia Guo; Bo Wang; Chong Wang; M A A Mamun; Ya Gao; Hong-Min Liu
Journal:  J Hematol Oncol       Date:  2021-04-07       Impact factor: 17.388

5.  Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition.

Authors:  Sara Petillo; Cristina Capuano; Rosa Molfetta; Cinzia Fionda; Abdelilah Mekhloufi; Chiara Pighi; Fabrizio Antonangeli; Alessandra Zingoni; Alessandra Soriani; Maria Teresa Petrucci; Ricciarda Galandrini; Rossella Paolini; Angela Santoni; Marco Cippitelli
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

Review 6.  [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].

Authors:  Qing Yu; Xiufang Xiong; Yi Sun
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

7.  Small molecules targeting the NEDD8·NAE protein-protein interaction.

Authors:  Chen-Ming Lin; Zhengyang Jiang; Zhe Gao; Maritess Arancillo; Kevin Burgess
Journal:  Chem Sci       Date:  2020-12-14       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.